New guidelines will help detect and study counterfeit medicines

Mar 24, 2009

New guidelines proposed by a group of international experts will help better study the prevalence and geography of counterfeit and other poor quality medicines that threaten public health across the world. The guidelines—called MEDQUARG, which stands for Medicine Quality Assessment Reporting Guidelines—are published in this week's open access journal PLoS Medicine.

A significant proportion of drugs consumed in the are of poor quality, many of which are counterfeit, say the authors, all experts on drug quality working in Kenya, Laos, Thailand, the UK, and the US. This begs the question—how can we translate evidence on best drug treatment outcomes into treatment policy if the medicines actually used have substantially inferior effectiveness compared with the medicines originally evaluated? There are no existing about the most appropriate sampling and reporting strategies for surveys.

Paul Newton and colleagues reviewed previous work on the quality of medicines and discuss the advantages and disadvantages of different study methods, including how to sample medicines for testing. They also reviewed how quality studies have been reported and suggest a checklist of items to be addressed in future studies

The authors invite comment on their guideline proposals, saying that "The objective of the consensus guidelines presented here is to guide surveys of medicine quality and how they are reported, and to provide a template for further development."

More information: Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, et al. (2009) Guidelines for field surveys of the quality of medicines: A proposal. PLoS Med 6(3): e1000052. doi:10.1371/journal.pmed.1000052 medicine.plosjournals.org/perl… journal.pmed.1000052

Source: Public Library of Science (news : web)

Explore further: FDA clears Novo Nordisk's weight loss drug Saxenda

add to favorites email to friend print save as pdf

Related Stories

How to treat fevers in African children up for debate

Jan 06, 2009

A new debate in the open access journal PLoS Medicine questions whether all African children with fever should be treated presumptively with antimalarial drugs, or if treatment should wait until laboratory tests confirm malari ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

Dec 22, 2014

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.